Orca Bio

Analyst, Data and Business Intelligence

Remote

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Analyst, Data & Business Intelligence

Employment Type: Regular, Full-Time Employee

Position Overview

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies, we hope to not only replace patients' blood and immune systems with healthy ones but also restore their lives.

The Analyst, Data & Business Intelligence will play a critical role in supporting Orca Bio’s commercial launch and ongoing business performance. This role will own the design, development, and deployment of data reporting infrastructure, field analytics dashboards, and performance measurement tools. The ideal candidate is highly analytical, detail-oriented, and thrives at the intersection of data, systems, and commercial execution. This position works closely with the Forecasting, Sales Operations, Case Management, and Market Access teams to ensure actionable insights are delivered across the organization.

Essential Duties & Key Responsibilities

Data Infrastructure & Analytics Execution

  • Build and manage the commercial data ecosystem (Salesforce/Veeva, PowerBI/Tableau, data warehouse, CRM integration).
  • Own ETL processes and data validation to ensure accurate, real-time reporting and compliance.
  • Develop field reporting tools (call activity, onboarding progress, IC performance, product ordering trends).
  • Manage master data inputs, ensure alignment with order management, and support business rule definition.
  • Partner with IT and external vendors on system configuration, access provisioning, and updates.

Performance Measurement & Intelligence

  • Deliver monthly and ad hoc dashboards for sales, onboarding, field engagement, and KPIs.
  • Identify key business trends and performance drivers; translate data into actionable insights.
  • Support commercial leadership with field activity dashboards, territory views, and targeting analytics.
  • Develop and maintain commercial KPIs and performance frameworks across functions.
  • Track incentive comp effectiveness, performance thresholds, and payout validation (in collaboration with Sales Ops).

Collaboration & Continuous Improvement

  • Act as commercial data subject matter expert (SME) across analytics platforms.
  • Collaborate cross-functionally with Case Management, Patient Services, Market Access, and Marketing to align on reporting needs.
  • Support business planning cycles by developing analytic reports and supporting forecast inputs.
  • Recommend and implement improvements to commercial analytics workflows and visualization tools.

Minimum Qualifications

  • Bachelor’s degree in business, statistics, data science, engineering, or related field.
  • 5+ years in commercial analytics, preferably in biotech/pharma.
  • Direct experience with business analytics and business intelligence tools.
  • Experience managing commercial data pipelines and field analytics.
  • High proficiency with Excel, SQL, and data visualization best practices.
  • Familiarity with CRM configuration, master data management, and IC analytics.
  • Excellent communication and collaboration skills with ability to translate data into insights.

Preferred Characteristics

  • Ability to prioritize in a dynamic, launch-focused environment.
  • Passion for building clean, scalable reporting infrastructure.
  • Curious and business-savvy mindset with a strong desire to drive impact through data.
  • Collaborative, team-first mentality with strong organizational awareness.

Company Information

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks.

Salary Information

The anticipated annual salary range for this job is based on prior experience in the role/industry, education, location, internal equity, and other job-related factors as permitted by law. For remote-based positions, the salary range may be adjusted based on geographic location.

Skills

Data Analysis
Business Intelligence
Salesforce
Veeva
Power BI
Tableau
Data Warehousing
CRM Integration
ETL
Data Validation
Reporting
Forecasting
Sales Operations
Market Access

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI